Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2026)

Updated

Precision Biosciences (DTIL) recorded Other Non-Current Assets of $26.33 million in fiscal Q2 2026 (quarter ended Jun 30, 2026), up 16.7% from $22.56 million a year earlier but down 0.6% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025 (ended Dec 31, 2025), Precision Biosciences reported Other Non-Current Assets of $206,000, down 99.1% from FY2024.

  • Annual Other Non-Current Assets has a five-year compound annual growth rate of -34.6% (FY2020 to FY2025).
  • Across earlier fiscal years, Other Non-Current Assets came in at $22.57 million in FY2024, $225,000 in FY2023 (-98.2%), $12.35 million in FY2022 (+166.0%) and $4.64 million in FY2021 (+169.7%).
  • Quarterly Other Non-Current Assets has ranged from $206,000 in fiscal Q4 2025 to $26.48 million in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Other Non-Current Assets rose in three of the last four quarters, with an average decline of 12.1%.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 400.4% in fiscal Q2 2022, against a decline of 99.1% in fiscal Q4 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $26.48 million (Q1 2026), $206,000 (Q4 2025) and $26.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Precision Biosciences 165.47 Mn -183.71 Mn - 26.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.33 Mn
Mar 31, 2026 26.48 Mn
Dec 31, 2025 206,000.00
Sep 30, 2025 26.34 Mn
Jun 30, 2025 22.56 Mn
Mar 31, 2025 22.57 Mn
Dec 31, 2024 22.57 Mn
Sep 30, 2024 22.58 Mn
Mar 31, 2024 238,000.00
Dec 31, 2023 225,000.00
Sep 30, 2023 234,000.00
Jun 30, 2023 619,000.00
Mar 31, 2023 2.75 Mn
Dec 31, 2022 12.35 Mn
Sep 30, 2022 9.52 Mn
Jun 30, 2022 9.33 Mn
Mar 31, 2022 4.66 Mn
Dec 31, 2021 4.64 Mn
Sep 30, 2021 4.22 Mn
Jun 30, 2021 1.87 Mn
API Access

Precision Biosciences Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=DTIL&period=max&api_key=YOUR_API_KEY